CogState Ltd
ASX:CGS

Watchlist Manager
CogState Ltd Logo
CogState Ltd
ASX:CGS
Watchlist
Price: 1.66 AUD 0.61% Market Closed
Market Cap: 280.2m AUD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one CGS stock under the Base Case scenario is 1.92 AUD. Compared to the current market price of 1.66 AUD, CogState Ltd is Undervalued by 13%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CGS Relative Value
Base Case
1.92 AUD
Undervaluation 13%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

4
P/S
P/S
Price to Sales
4
vs History
61
vs Industry
37
Median 3Y
4
Median 5Y
4.2
Industry
2.2
Forward
3.9
More Details
25.6
P/E
P/E
Price to Earnings
25.6
vs History
61
vs Industry
28
Median 3Y
26.7
Median 5Y
27.3
Industry
21.9
Forward
25.3
More Details
16.7
P/OCF
P/OCF
Price to OCF
16.7
vs History
73
vs Industry
29
Median 3Y
22.2
Median 5Y
22.2
Industry
14.1
More Details
20.3
P/FCFE
P/FCFE
Price to FCFE
20.3
vs History
44
vs Industry
27
Median 3Y
29.8
Median 5Y
15.6
Industry
19.8
More Details
4.2
P/B
P/B
Price to Book Value
4.2
vs History
68
vs Industry
26
Median 3Y
4.4
Median 5Y
5.3
Industry
2.1
More Details
3.3
EV/S
EV/S
Enterprise Value to Sales
3.3
vs History
66
vs Industry
43
Median 3Y
3.3
Median 5Y
3.5
Industry
2.4
Forward
3.2
More Details
5.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
5.4
vs History
71
vs Industry
50
Median 3Y
5.9
Median 5Y
7
Industry
4.9
More Details
14.8
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
14.8
vs History
65
vs Industry
31
Median 3Y
19.2
Median 5Y
22.1
Industry
11.5
Forward
12.5
More Details
14.8
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
14.8
vs History
65
vs Industry
36
Median 3Y
19.2
Median 5Y
22.1
Industry
15.7
Forward
16.3
More Details
13.7
EV/OCF
EV/OCF
Enterprise Value to OCF
13.7
vs History
73
vs Industry
36
Median 3Y
18.8
Median 5Y
18.4
Industry
14.1
More Details
16.5
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
16.5
vs History
44
vs Industry
31
Median 3Y
20.5
Median 5Y
12.1
Industry
17.6
More Details
7.4
EV/IC
EV/IC
Enterprise Value to IC
7.4
vs History
46
vs Industry
15
Median 3Y
6.6
Median 5Y
6.8
Industry
1.8
More Details

Multiples Across Competitors

CGS Competitors Multiples
CogState Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
CogState Ltd
ASX:CGS
285.4m AUD 4 25.6 14.8 14.8
US
Veeva Systems Inc
NYSE:VEEV
46.2B USD 16.2 59.2 49.5 52.1
US
Cerner Corp
LSE:0R00
31.3B USD 5.4 53.1 21.9 43.2
AU
Pro Medicus Ltd
ASX:PME
32.2B AUD 168.6 327.3 229 229
US
Doximity Inc
NYSE:DOCS
11.7B USD 20.4 52.2 44.6 46.7
JP
M3 Inc
TSE:2413
1.3T JPY 4.5 31.8 18 21.7
SE
Sectra AB
STO:SECT B
67.4B SEK 32.6 119.6 -147.5 -147.5
US
Waystar Holding Corp
NASDAQ:WAY
6.8B USD 7 260.9 23.6 50.6
US
Inspire Medical Systems Inc
NYSE:INSP
3.8B USD 4.5 56.9 58.3 68.6
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
266.9B INR 0 0 0 0
CN
Winning Health Technology Group Co Ltd
SZSE:300253
21.6B CNY 8.2 282.7 97.8 97.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
AU
CogState Ltd
ASX:CGS
Average EV/EBITDA: 62
14.8
31%
0.5
US
Veeva Systems Inc
NYSE:VEEV
49.5
38%
1.3
US
C
Cerner Corp
LSE:0R00
21.9
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
229
38%
6
US
Doximity Inc
NYSE:DOCS
44.6
21%
2.1
JP
M3 Inc
TSE:2413
18
13%
1.4
SE
Sectra AB
STO:SECT B
Negative Multiple: -147.5 N/A N/A
US
W
Waystar Holding Corp
NASDAQ:WAY
23.6
18%
1.3
US
Inspire Medical Systems Inc
NYSE:INSP
58.3
90%
0.6
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
Not Available N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
97.8
48%
2
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
AU
CogState Ltd
ASX:CGS
Average EV/EBIT: 69.4
14.8
22%
0.7
US
Veeva Systems Inc
NYSE:VEEV
52.1
39%
1.3
US
C
Cerner Corp
LSE:0R00
43.2
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
229
36%
6.4
US
Doximity Inc
NYSE:DOCS
46.7
22%
2.1
JP
M3 Inc
TSE:2413
21.7
N/A N/A
SE
Sectra AB
STO:SECT B
Negative Multiple: -147.5 N/A N/A
US
W
Waystar Holding Corp
NASDAQ:WAY
50.6
40%
1.3
US
Inspire Medical Systems Inc
NYSE:INSP
68.6
64%
1.1
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
Not Available N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
97.8
47%
2.1

See Also

Summary
CGS intrinsic value, competitors valuation, and company profile.
DCF Valuation
CGS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CGS stock valuation using valuation multiples.
Wall Street Estimates
CGS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CGS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 265,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.